Tripod Therapeutics develops a first in class anti-cancer drug that targets a novel mechanism of action related to Proteasome dynamics. The technology was developed by Nobel laureate Professor Aaron Ciechanover and his team from the Israeli Institute of Technology ("Technion").
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Proteasome, Ubiquitin, Cancer, oncology.
Tripod Therapeutics Questions
Tripod Therapeutics's website is http://www.tripodtherapeutics.com
Tripod Therapeutics's LinkedIn profile is https://www.linkedin.com/company/tripod-therapeutics
Tripod Therapeutics's industry is
Biotechnology Research
Tripod Therapeutics's top competitors are
Cannalife Ltd,
Ticure,
Fulfill Food & Beverages, Llc,
Celleste Bio,
Bio-D4m,
Pepvic,
Aporx,
Daisy Appeal - Hull And East Yorkshire Medical Research Centre,
Agbiopro,
Sea2cell.
Tripod Therapeutics's categories are Biotechnology Research
Tripod Therapeutics's founding year is 2021
